Literature DB >> 8515423

Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanine.

J A Secrist1, S Niwas, J D Rose, Y S Babu, C E Bugg, M D Erion, W C Guida, S E Ealick, J A Montgomery.   

Abstract

Alicyclic and heteroalicyclic derivatives of 9-deazaguanine (2-amino-1,5-dihydro-4H-pyrrolo[3,2-d] [pyrimidin-4-one) are, with one exception, potent inhibitors of purine nucleoside phosphorylase (PNP) equaling the corresponding 9-arylmethyl derivatives previously investigated. The mode of binding of these compounds to PNP was determined by X-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515423     DOI: 10.1021/jm00065a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

Review 1.  Structural analyses reveal two distinct families of nucleoside phosphorylases.

Authors:  Matthew J Pugmire; Steven E Ealick
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.

Authors:  Kartik W Temburnikar; Christina R Ross; Gerald M Wilson; Jan Balzarini; Brian M Cawrse; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2015-06-16       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.